WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 126–150 of 232 international scientific journals (Oncology)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #126 | Oncotargets and Therapy ISSN: 1178-6930 | 2.4 | 100 | Q3 | 0.8Q2 | CAS Tier 3 | 0% | 448 | Dove Medical Press Ltd. |
| #127 | Radiology and Oncology ISSN: 1318-2099 / 1581-3207 | 2.3 | 49 | Q3 | 0.641Q2 | CAS Tier 3 | 4.8% | 71 | Walter de Gruyter |
| #128 | Breast Cancer-Basic and Clinical Research ISSN: 1178-2234 | 2.2 | 40 | Q3 | 0.816Q2 | CAS Tier 4 | 0% | 22 | SAGE Publishing |
| #129 | Cancer Investigation ISSN: 0735-7907 / 1532-4192 | 2.2 | 97 | Q3 | 0.495Q3 | CAS Tier 4 | 0% | 102 | Informa Healthcare |
| #130 | Journal of the Egyptian National Cancer Institute ISSN: 1110-0362 / 2589-0409Diamond OA | 2.2 | 33 | Q3 | 0.551Q3 Diamond OA | CAS Tier 4 | 0% | 38 | SpringerOpen |
| #131 | Asia-Pacific Journal of Clinical Oncology ISSN: 1743-7555 / 1743-7563 | 2.1 | 49 | Q3 | 0.565Q2 | CAS Tier 4 | 0% | 118 | Wiley-Blackwell Publishing Ltd |
| #132 | Cancer Informatics ISSN: 1176-9351 | 2.1 | 42 | Q3 | 0.539Q3 | CAS Tier 4 | 4.2% | 18 | Libertas Academica |
| #133 | Cancer Journal ISSN: 1528-9117 / 1540-336X | 2.1 | 110 | Q3 | 0.869Q2 | CAS Tier 4 | 0% | 65 | Wolters Kluwer Health |
| #134 | Oncologie ISSN: 1292-3818 / 1765-2839 | 2.1 | 15 | Q3 | 0.391Q3 | CAS Tier 4 | 7.1% | 44 | Tech Science Press |
| #135 | Translational Cancer Research ISSN: 2218-676X / 2219-6803 | 2.1 | 47 | Q3 | 0.524Q2 | CAS Tier 4 | 6.7% | 519 | AME Publishing Company |
| #136 | Clinical Advances in Hematology & Oncology ISSN: 1543-0790 | 2 | 47 | Q4 | 0.283Q3 | CAS Tier 4 | 0% | 71 | Millenium Medical Publishing, Inc. |
| #137 | Hepatic Oncology ISSN: 2045-0923 / 2045-0931 | 2 | 5 | Q4 | 0.411Q3 | CAS Tier 4 | 0% | 7 | Future Medicine Ltd |
| #138 | Oncology-New York ISSN: 0890-9091 | 2 | 87 | Q4 | 0.534Q3 | CAS Tier 4 | 0% | 1 | UBM Medica Healthcare Publications |
| #139 | International Journal of Breast Cancer ISSN: 2090-3170 / 2090-3189 | 1.9 | 27 | Q4 | 0.585Q3 | CAS Tier 3 | 0% | 12 | Hindawi Limited |
| #140 | Molecular and Clinical Oncology ISSN: 2049-9450 / 2049-9469 | 1.9 | 27 | Q4 | 0.511Q3 | CAS Tier 4 | 0% | 254 | Spandidos Publications UK |
| #141 | Oncology ISSN: 0030-2414 / 1423-0232 | 1.9 | 112 | Q4 | 0.596Q2 | CAS Tier 4 | 4% | 91 | S. Karger AG |
| #142 | American Journal of Clinical Oncology-Cancer Clinical Trials ISSN: 0277-3732 / 1537-453X | 1.8 | 95 | Q4 | 0.647Q3 | CAS Tier 4 | 0% | 94 | Lippincott Williams and Wilkins Ltd. |
| #143 | Anticancer Research ISSN: 0250-7005 / 1791-7530 | 1.8 | 145 | Q4 | 0.58Q2 | CAS Tier 4 | 18.8% | 703 | International Institute of Anticancer Research |
| #144 | Cancer Biomarkers ISSN: 1574-0153 / 1875-8592 | 1.8 | 60 | Q4 | 0.572Q2 | CAS Tier 4 | 0% | 121 | IOS Press |
| #145 | Prostate Cancer ISSN: 2090-3111 / 2090-312X | 1.8 | 17 | Q4 | 0.602Q2 | CAS Tier 4 | 0% | 7 | Hindawi Limited |
| #146 | ESMO Gastrointestinal Oncology ISSN: 2949-8198 | 1.7 | 6 | Q4 | 0.914Q1 | — | N/A | — | ELSEVIER |
| #147 | Journal of Adolescent and Young Adult Oncology ISSN: 2156-5333 / 2156-535X | 1.6 | 39 | Q4 | 0.629Q2 | CAS Tier 4 | 16.7% | 90 | Mary Ann Liebert Inc. |
| #148 | eCancerMedicalScience ISSN: 1754-6605 | 1.5 | 54 | Q4 | 0.503Q3 | CAS Tier 4 | 0% | 173 | ecancer Global Foundation |
| #149 | Journal of Cancer Research and Therapeutics ISSN: 0973-1482 / 0974-1127 | 1.4 | 58 | Q4 | 0.425Q3 | CAS Tier 4 | 21.4% | 252 | Wolters Kluwer Medknow Publications |
| #150 | Oncology Research and Treatment ISSN: 2296-5270 / 2296-5262 | 1.4 | 59 | Q4 | 0.482Q3 | CAS Tier 4 | 5% | 67 | S. Karger AG |